In light of the change in recommendation regarding the administration of COVID-19 AstraZeneca in those under 50 years, we are excited to be hosting a special clinical feature event on Thrombosis with thrombocytopenia syndrome (TTS) & COVID-19 AstraZeneca. Our panel will be giving background on what this new syndrome is and explore its association with the vaccine. We will also discuss the risk-versus-benefit assessment and how this new recommendation will impact confidence in the vaccine rollout.
The session will run for approximately 1.5 hours, including an opportunity for live Q&A from the audience.
To register for our special clinical feature event, please follow these steps:
- Sign up if you are a new user or Sign in to your profile to access the event.
- Once you have Signed up/Signed in, please click ‘take this course’ to enrol into this event. The event details and links will then be accessible.
- A confirmation email will be sent to your nominated email address confirming your registration and will also include the Zoom link for the event.
If you require any assistance with signing up, please contact firstname.lastname@example.org
For more information on this webinar, please contact email@example.com